AGP Picks
View all

Delaware Health News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Delaware Health News Online.

Press releases published on November 16, 2026

Commure Acquires Elaborate to Cure the Clinician Inbox
Enlivex Announces Pricing of $7.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Fareon Presents Research Linking Microtesla Magnetic Therapy to Improvements in Cognitive Function and Biological Markers of Brain Health at Society for Neuroscience (SfN) Annual Meeting
Allarity Therapeutics Expands Phase 2 Stenoparib Trial to Three Ovarian Cancer Patient Cohorts
Davion Healthcare Plc Agrees to Terms in Acquisition of Independence Care Homecare Network
AVITA Medical Reports Complete Cohealyx I Data in Full-Thickness Wounds Showing Earlier Graft Readiness and Six-Month Healing Outcomes
Clearmind Achieves Full Enrollment for Part C in CMND-100 Phase I/IIa Trial, Marking Key Clinical Milestone
Monaghan Medical Earns 18th AARC Zenith Award
SciSparc: Former National Security Advisor to Prime Minister Benjamin Netanyahu Renowned AI Prof. Jacob Nagel Joins the Company’s SAB
Rein Therapeutics Announces Preliminary Blinded Phase 2 RENEW Data Showing Encouraging Lung Function Trends in Patients with Idiopathic Pulmonary Fibrosis and Reports Third Quarter 2026 Financial Results
Moleculin Biotech Reports Third Quarter 2026 Financial Results as Pivotal MIRACLE Trial Advances Toward Key Q1 2027 Data Readout
Medicus Pharma Announces Closing of $4.25 Million CEO-Led Equity Financings and $10.5 Million Debt Exchange
Cerenome Reports Interim ReSPECT-LM Data Supporting Repeat Dosing of REYOBIQ™ in Leptomeningeal Metastases at the 2026 SNO Annual Meeting
Grey Matters Announces Accreditation for its Flagship NovaScan Neuroimaging Clinics™ Location in Florida and Completes Medicare and Medicaid Enrollment
Surgery Partners, Inc. Announces Commencement of Consent Solicitation Relating to Surgery Center Holdings, Inc.’s 7.250% Senior Notes due 2032
Larimar Therapeutics Reports Third Quarter 2026 Financial and Business Update
NervGen Reports Third Quarter 2026 Financial Results and Provides Business Updates
MapLight Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Prelude Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Invivyd Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Delaware Health News Online

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.